Truly appreciate if Bursa can stop / suspend the RSS as this is a tool used to manipulate the share price. In my opinion its departs from the very principles of investing. The share price is no longer based on company performance and fundamentals but manipulation.

Also truly appreciate if Bursa can stop / suspend IBs who has warrants on a particular company and yet write research analysis of the said company. Most definitely these IBs will use their analysis to manipulate the share price to benefit their warrants. Isn’t this conflict of interest?

Look at top glove. Holding steady. So this is clear manipulation on Supermax.

Truly appreciate if Bursa can stop / suspend the RSS as this is a tool used to manipulate the share price. In my opinion its departs from the very principles of investing. The share price is no longer based on company performance and fundamentals but manipulation.

Also truly appreciate if Bursa can stop / suspend IBs who has warrants on a particular company and yet write research analysis of the said company. Most definitely these IBs will use their analysis to manipulate the share price to benefit their warrants. Isn’t this conflict of interest?

Truly appreciate if Bursa can stop / suspend the RSS as this is a tool used to manipulate the share price. In my opinion its departs from the very principles of investing. The share price is no longer based on company performance and fundamentals but manipulation.

Also truly appreciate if Bursa can stop / suspend IBs who has warrants on a particular company and yet write research analysis of the said company. Most definitely these IBs will use their analysis to manipulate the share price to benefit their warrants. Isn’t this conflict of interest?

Truly appreciate if the 4 big glove companies and the other glove manufactures could announce officially their revenue reports for just the month of January 2021 which is since the release of vaccines and adaptation of new norms. Let us all know once and for all whether vaccines and new norms generate demands for glove. In most countries now from the picture on the web, gloves are being used for every vaccination, manufacturing, distribution chain, etc, etc. Is this the catalyst for demand on gloves?. Since vaccination will continue for years to come, will this mean continuous glove demand? With the emergence of virus variants, will this increase the glove demand?

Truly appreciate if the 4 big glove companies and the other glove manufactures could announce officially their revenue reports for just the month of January 2021 which is since the release of vaccines and adaptation of new norms. Let us all know once and for all whether vaccines and new norms generate demands for glove. In most countries now from the picture on the web, gloves are being used for every vaccination, manufacturing, distribution chain, etc, etc. Is this the catalyst for demand on gloves?. Since vaccination will continue for years to come, will this mean continuous glove demand? With the emergence of virus variants, will this increase the glove demand?

Truly appreciate if the 4 big glove companies and the other glove manufactures could announce officially their revenue reports for just the month of January 2021 which is since the release of vaccines and adaptation of new norms. Let us all know once and for all whether vaccines and new norms generate demands for glove. In most countries now from the picture on the web, gloves are being used for every vaccination, manufacturing, distribution chain, etc, etc. Is this the catalyst for demand on gloves?. Since vaccination will continue for years to come, will this mean continuous glove demand? With the emergence of virus variants, will this increase the glove demand?

Truly appreciate if the 4 big glove companies and the other glove manufactures could announce officially their revenue reports for just the month of January 2021 which is since the release of vaccines and adaptation of new norms. Let us all know once and for all whether vaccines and new norms generate demands for glove. In most countries now from the picture on the web, gloves are being used for every vaccination, manufacturing, distribution chain, etc, etc. Is this the catalyst for demand on gloves?. Since vaccination will continue for years to come, will this mean continuous glove demand? With the emergence of virus variants, will this increase the glove demand?

Truly appreciate if the 4 big glove companies and the other glove manufactures could announce officially their revenue reports for just the month of January 2021 which is since the release of vaccines and adaptation of new norms. Let us all know once and for all whether vaccines and new norms generate demands for glove. In most countries now from the picture on the web, gloves are being used for every vaccination, manufacturing, distribution chain, etc, etc. Is this the catalyst for demand on gloves?. Since vaccination will continue for years to come, will this mean continuous glove demand? With the emergence of virus variants, will this increase the glove demand?

Truly appreciate if the 4 big glove companies and the other glove manufactures could announce officially their revenue reports for just the month of January 2021 which is since the release of vaccines and adaptation of new norms. Let us all know once and for all whether vaccines and new norms generate demands for glove. In most countries now from the picture on the web, gloves are being used for every vaccination, manufacturing, distribution chain, etc, etc. Is this the catalyst for demand on gloves?. Since vaccination will continue for years to come, will this mean continuous glove demand? With the emergence of virus variants, will this increase the glove demand?

Truly appreciate if the 4 big glove companies and the other glove manufactures could announce officially their revenue reports for just the month of January 2021 which is since the release of vaccines and adaptation of new norms. Let us all know once and for all whether vaccines and new norms generate demands for glove. In most countries now from the picture on the web, gloves are being used for every vaccination, manufacturing, distribution chain, etc, etc. Is this the catalyst for demand on gloves?. Since vaccination will continue for years to come, will this mean continuous glove demand? With the emergence of virus variants, will this increase the glove demand?

Agreed. Unlike Top Glove. The owners of Top Glove are not greedy. They share their success with the retailers through good dividends and maintain the share price to being stable.

Yes IBs and RSS win. Supermax PAT is great but dividend and share price hopeless. Pointless have strong fundamentals.

Disgraceful. Extremely disappointed with Supermax management. At least Top Glove is holding steady.

Good news and this will increase the demand for medical gloves locally in Malaysia, exponentially.

https://www.astroawani.com/video-malaysia/awani-tonight-covid-19-vaccination-registration-starts-march-1890393

See the video where in Malaysia vaccinations use gloves. Same in all counties in the world to protect the medical staff from the virus and variants.

https://www.cnn.com/coronavirus-latest

Johnson & Johnson CEO says he thinks people will need an annual Covid-19 vaccine for many years to come
The Chief Executive Officer of Johnson & Johnson said Tuesday that people may need an annual Covid-19 shot for many years to come in order to be protected against variants of the virus.

“Unfortunately, as (the virus) spreads it can also mutate,” Alex Gorsky told CNBC’s Meg Tirrell Tuesday during the network’s Healthy Returns Spotlight event. “Every time it mutates, it’s almost like another click of the dial so to speak where we can see another variant, another mutation that can have an impact on its ability to fend of antibodies or to have a different kind of response not only to a therapeutic but also to a vaccine.”

https://www.cnn.com/coronavirus-latest

Johnson & Johnson CEO says he thinks people will need an annual Covid-19 vaccine for many years to come
The Chief Executive Officer of Johnson & Johnson said Tuesday that people may need an annual Covid-19 shot for many years to come in order to be protected against variants of the virus.

“Unfortunately, as (the virus) spreads it can also mutate,” Alex Gorsky told CNBC’s Meg Tirrell Tuesday during the network’s Healthy Returns Spotlight event. “Every time it mutates, it’s almost like another click of the dial so to speak where we can see another variant, another mutation that can have an impact on its ability to fend of antibodies or to have a different kind of response not only to a therapeutic but also to a vaccine.”

https://www.cnn.com/coronavirus-latest

Johnson & Johnson CEO says he thinks people will need an annual Covid-19 vaccine for many years to come
The Chief Executive Officer of Johnson & Johnson said Tuesday that people may need an annual Covid-19 shot for many years to come in order to be protected against variants of the virus.

“Unfortunately, as (the virus) spreads it can also mutate,” Alex Gorsky told CNBC’s Meg Tirrell Tuesday during the network’s Healthy Returns Spotlight event. “Every time it mutates, it’s almost like another click of the dial so to speak where we can see another variant, another mutation that can have an impact on its ability to fend of antibodies or to have a different kind of response not only to a therapeutic but also to a vaccine.”

Wrong Germfinder888. Look at the Worldmeter, new cases and new deaths are increasing again mainly due to Virus Variant LOL.
Glove demand will continue to rise.

https://news.yahoo.com/vaccine-distribution-continues-vary-state-090011473.html
Variant cases in US spike by 73%, with Florida leading the way.

The country now reports 944 cases of variants that spread more easily, bypass treatments and immunities, or both

Tuesday night's report still shows three known cases of P.1, a variant first spotted in Brazil that appears to bypass immunities, and now nine cases of B.1.351, a variant that took over South Africa and resists some treatments and vaccines

https://news.yahoo.com/vaccine-distribution-continues-vary-state-090011473.html
Variant cases in US spike by 73%, with Florida leading the way.

The country now reports 944 cases of variants that spread more easily, bypass treatments and immunities, or both

Tuesday night's report still shows three known cases of P.1, a variant first spotted in Brazil that appears to bypass immunities, and now nine cases of B.1.351, a variant that took over South Africa and resists some treatments and vaccines

Now there is a new Covid 19 Variant – Kent Variant.
https://www.bbc.com/news/uk-england-manchester-55986900
Manchester Covid surge tests as mutation of Kent variant confirmed

Now there is a new Covid 19 Variant – Kent Variant.
https://www.bbc.com/news/uk-england-manchester-55986900
Manchester Covid surge tests as mutation of Kent variant confirmed

https://news.yahoo.com/vaccine-distribution-continues-vary-state-090011473.html
Variant cases in US spike by 73%, with Florida leading the way.

The country now reports 944 cases of variants that spread more easily, bypass treatments and immunities, or both

Tuesday night's report still shows three known cases of P.1, a variant first spotted in Brazil that appears to bypass immunities, and now nine cases of B.1.351, a variant that took over South Africa and resists some treatments and vaccines

https://news.yahoo.com/vaccine-distribution-continues-vary-state-090011473.html
Variant cases in US spike by 73%, with Florida leading the way.

The country now reports 944 cases of variants that spread more easily, bypass treatments and immunities, or both

Tuesday night's report still shows three known cases of P.1, a variant first spotted in Brazil that appears to bypass immunities, and now nine cases of B.1.351, a variant that took over South Africa and resists some treatments and vaccines

Here you go. Again another fact of the vaccine.
https://www.dw.com/en/coronavirus-digest-german-nursing-home-sees-outbreak-after-vaccines/a-56491823

Fourteen residents at a German nursing home have tested positive despite receiving two vaccine doses.

Local officials in the district of Osnabruck, Germany, said there was an outbreak of the UK variant of coronavirus at a nursing home in Belm.
The outbreak came despite all of its residents already receiving two doses of the BioNTech-Pfizer vaccine, with their last shot on January 25. A local government spokesperson said 14 residents tested positive for the virus at the end of last week
So it seemed that the Pfizer vaccine even after 2 doses is not effective against the UK Virus Variant.

Is the Vaccination program failing?

Why did Pfizer pull out from India, the World’s 2nd largest population when India requested for trial. ?

Here you go. Again another fact of the vaccine.
https://www.dw.com/en/coronavirus-digest-german-nursing-home-sees-outbreak-after-vaccines/a-56491823

Fourteen residents at a German nursing home have tested positive despite receiving two vaccine doses.

Local officials in the district of Osnabruck, Germany, said there was an outbreak of the UK variant of coronavirus at a nursing home in Belm.
The outbreak came despite all of its residents already receiving two doses of the BioNTech-Pfizer vaccine, with their last shot on January 25. A local government spokesperson said 14 residents tested positive for the virus at the end of last week
So it seemed that the Pfizer vaccine even after 2 doses is not effective against the UK Virus Variant.

Is the Vaccination program failing?

Why did Pfizer pull out from India, the World’s 2nd largest population when India requested for trial. ?

Now there is a new Covid 19 Variant – Kent Variant.
https://www.bbc.com/news/uk-england-manchester-55986900
Manchester Covid surge tests as mutation of Kent variant confirmed

Now there is a new Covid 19 Variant – Kent Variant.
https://www.bbc.com/news/uk-england-manchester-55986900
Manchester Covid surge tests as mutation of Kent variant confirmed

Here you go. Again another fact of the vaccine.
https://www.dw.com/en/coronavirus-digest-german-nursing-home-sees-outbreak-after-vaccines/a-56491823

Fourteen residents at a German nursing home have tested positive despite receiving two vaccine doses.

Local officials in the district of Osnabruck, Germany, said there was an outbreak of the UK variant of coronavirus at a nursing home in Belm.
The outbreak came despite all of its residents already receiving two doses of the BioNTech-Pfizer vaccine, with their last shot on January 25. A local government spokesperson said 14 residents tested positive for the virus at the end of last week
So it seemed that the Pfizer vaccine even after 2 doses is not effective against the UK Virus Variant.

Is the Vaccination program failing?

Why did Pfizer pull out from India, the World’s 2nd largest population when India requested for trial. ?
.

Here you go. Again another fact of the vaccine.
https://www.dw.com/en/coronavirus-digest-german-nursing-home-sees-outbreak-after-vaccines/a-56491823

Fourteen residents at a German nursing home have tested positive despite receiving two vaccine doses.

Local officials in the district of Osnabruck, Germany, said there was an outbreak of the UK variant of coronavirus at a nursing home in Belm.
The outbreak came despite all of its residents already receiving two doses of the BioNTech-Pfizer vaccine, with their last shot on January 25. A local government spokesperson said 14 residents tested positive for the virus at the end of last week
So it seemed that the Pfizer vaccine even after 2 doses is not effective against the UK Virus Variant.

Is the Vaccination program failing?

Why did Pfizer pull out from India, the World’s 2nd largest population when India requested for trial. ?
.

Actually as Malaysians, we should all be protecting all Malaysian glove companies and not abuse them.
These are truly Malaysian companies with raw materials from Malaysia. Gloves are truly Malaysia from raw Material to finish product.
And this finish product - Gloves are used to save billions of lives. Lets be proud of them and their achievement, support, encourage and protect them.

Correct, now no RSS that is why its only -0.05. Now remove the IB manipulation and you will see the true value of Supermax. What are you all afraid off - true transparency

Price maintaining around 6.30 because of warrant this month. Manipulation again. After Feb, hopefully no more manipulation. Then you will see the true value of Supermax.

The only reason its red is because of manipulation. But not for long. Fundamentals and demand will always prevail.

See IB still trying to manipulate the share price but they are running out of share bank.

Yes, but will be required annually to combat virus mutation. So Glove will continue to be in demand LOL. That is why USA is budgeting billions for annual supply.

The world is coping. COPING is the word. Coping to live with Covid 19.

Vaccine jabs will be a yearly affair. As the virus continues to mutate, vaccine booster jabs will continue to be required. It will be like the flu vaccine. Therefore Glove will continue to be in huge demand.

Green. Market is finally realising the demand for glove for many years to come.

If IBs stop manipulating and RSS is halted, you will then see the true price of Supermax - purely based on demand / supply and forward looking.

All these will require GLOVE, GLOVE, GLOVE. No brainer

Its not the number of new cases but the vaccine program that will drive the demand for gloves. Especially when it becomes an annual affair. That is why Biden (USA) has decided on an annual demand for gloves. Not just this year. But for many many years ahead. Again no brainer.

That is why Supermax has position itself locally in the USA (manufacturing plant), UK and Canada. To tap the annual demand for gloves. Supermax new revenue will start coming in by year end and annually for many years ahead. Forward thinking.

Also ASP will continue to rise. Manufacturing cost will be higher in the USA. US Government will still purchase due local product. In order to be profitable, ASP will have to be increased. No brainer.

The TRUTH is finally out.

Booster shots are likely in the UK this fall to combat coronavirus variants - a sign vaccines may become an annual affair

Also note that all round the world medical staff are beginning to realise the safety concerns and are using gloves for vaccination.

https://www.healthline.com/health-news/you-can-still-spread-develop-covid-19-after-getting-a-vaccine-what-to-know

The vaccine does not prevent Covid 19 infection. vaccine doesn’t prevent coronavirus infection. It helps protect against serious illnesses. It helps you fight it when you get it. So even if you have been vaccinated, you can still be infected by the virus. That is why gloves are crucial.

Leading vaccine scientists are calling for a rethink of the goals of vaccination programmes, saying that herd immunity through vaccination is unlikely to be possible because of the emergence of variants like that in South Africa.

The comments came as the University of Oxford and AstraZeneca acknowledged that their vaccine will not protect people against mild to moderate Covid illness caused by the South African variant. The Oxford vaccine is the mainstay of the UK’s immunisation programme and vitally important around the world because of its low cost and ease of use.

The findings came from a study involving more than 2,000 people in South Africa. They followed results from two vaccines, from Novavax and Janssen, which were trialled there in recent months and were found to have much reduced protection against the variant – at about 60%. Pfizer/BioNTech and Moderna have also said the variant affects the efficacy of their vaccines, although on the basis of lab studies only.

A New York resident died on Sunday morning shortly after receiving the COVID vaccine, but state health officials maintain that "the vaccine is safe," the New York Post reported.

The elderly man, who was in his 70s, collapsed about 25 minutes after being administered the COVID vaccine as he left the Jacob Javits Convention Center vaccination site in Manhattan, Dr. Howard Zucker, the New York state health commissioner, said in a statement obtained by the Post.

The statement from Zucker also suggested "the man did not have any allergic reaction to the vaccine," as no adverse effects or signs of distress were observed during the 15-minute observation period following his inoculation.

The Centers for Disease Control and Prevention maintains that severe adverse reactions to the COVID vaccine occur "rarely," saying the chance of this happening is 10 cases in over 4 million

(CNN)South Africa has paused its rollout of the Oxford-AstraZeneca coronavirus vaccine after a study showed that it offered "minimal protection" against mild or moderate illness caused by the more contagious virus variant first identified there, known as B.1.351.

The findings, which come a week after the first million doses of the Oxford-AstraZeneca vaccine arrived in South Africa, are a damaging setback for the country's efforts to curtail the pandemic. More than 46,000 people are known to have died from Covid-19 there, and overall cases, which have topped 1.4 million, are now largely being driven by the new variant.
It's also a big blow for the Oxford-AstraZeneca vaccine, which has been hailed for its low cost and easy storage as one of the world's best hopes for defeating the virus. And the study is yet another worrying sign of the risks that new mutations pose to vaccine development and deployment, with herd immunity appearing increasingly less achievable.
The B.1.351 variant has been identified in at least 41 countries, including the United States, according to the World Health Organization (WHO). Other variants first spotted in the United Kingdom and Brazil have been detected in dozens more. And they're spreading rapidly.
It was not clear from the study, which has not yet been peer reviewed, whether the Oxford-AstraZeneca vaccine protected against severe disease from the B.1.351 variant. The 2,000 clinical trial participants were mostly young healthy adults, unlikely to become severely ill. But based on immune responses detected in their blood samples, scientists said there was "still some hope" that the vaccine could protect against more severe cases.
An AstraZeneca spokesperson said in a statement that the company was working with Oxford University to adapt the vaccine against the B.1.351 variant so "it is ready for autumn delivery should it be needed." Several other manufacturers have said they are trying to address the issue of variants by developing booster shots.
WHO's independent vaccine panel will meet Monday to discuss the AstraZeneca vaccine and what the new study means for vaccines going forward.

Yes. Believe in Karma. Supermax will recover from the manipulation.